Description
Act IL-32 is a new target in cancer and cardiovascular therapeutics.
Features
Size: 5 X 96 T
Standard range: 97-1500 pg/ml
Sensitivity: 30 pg/ml
Specificity: human IL-32
Sample type: serum, recombinant human IL-32 derived human cells
Dilution Factor: N/A
Intra-CV: 4-6%
Inter-CV: 8-10%
Data Sheet: PDF
Due IL-32 has short life in the circulating samples, please add enzyme inhibitors in to samples ASAP.